“…As mentioned above EPO in various studies has been reported to exert number of important actions like anti-oxidative (Genc et al, 2004;Signore et al, 2006;Xue et al, 2007;Wang et al, 2009), neuroprotective (Morishita et al, 1997;Lewczuk et al, 2000;Siren et al, 2001b), neurotrophic (Viviani et al, 2005) effects and a vital role in hippocampal LTP (Adamcio et al, 2008;El-Kordi et al, 2009). EPO has also shown to exert potential anti-inflammatory actions (Rui et al, 2005;Liu et al, 2006) and role of inflammation in the pathobiology of AD is well documented (Granic et al, 2009;Salminen et al, 2009). Therefore, with support from literature and data in hand it may be proposed that EPO mediated beneficial effect in STZ (i.c.v.…”